Illumina shares tumbled 8% Friday on investor concerns about the future of the gene-sequencing equipment maker’s business in ...

Precision Medicine Is the Future Of Healthcare When it comes to applied hard sciences, a source of progress has been more precise measurements and tools. This is especially true in physics and ...

Gene sequencing machine maker Illumina forecast 2025 revenue largely below Wall Street estimates on Thursday, signaling ...

Illumina Protein Prep™, powered by SOMAmer® technology, a next-generation sequencing (NGS) based solution that will help scale access to proteomic insight Illumina, Inc. (NASDAQ:ILMN ...

Investing.com -- TD Cowen downgraded Illumina Inc (NASDAQ:ILMN) to "Hold" following the company's fourth-quarter earnings, citing weaker-than-expected next-generation sequencing (NGS) consumable ...

(RTTNews) - Below are the earnings highlights for Illumina Inc. (ILMN): Earnings: $187 million in Q4 vs. -$176 million in the same period last year. EPS: $1.17 in Q4 vs. -$1.11 in the same period ...

More than 60 per cent of the world’s genetic sequencing data is generated by Illumina’s machines. After being blacklisted by Beijing, the company’s stock price fell 5 per cent. 02:52 China ...

In a case that had been closely watched across multiple industries, Illumina chose to divest Grail in the light of legal action from the European Commission and the US Federal Trade Commission.

KENNEDY SPACE CENTER — NASA showcased the next lunar lander from Intuitive Machines on Friday afternoon, which is the same company to be the first commercial business to land on the moon.

And later this month, Intuitive Machines second lunar lander, Athena, will liftoff atop a SpaceX Falcon 9 with its own NASA science and technology demonstrations. It will also carry a robot ...